26

nanotimes

Companies Facts

cial Officer of The Dow Chemical Company. The Partners have already set priorities for joint potential projects. The emphasis will be on large-scale projects based on nanotechnologies with the aim of attracting cooperation from major corporations and regions in Russia and developing intellectual property.

Furthermore, Dow Chemical achieved sales of $13.8 billion in the fourth quarter of 2010, a 22% increase compared with the same period last year. Double-digit sales increases were also reported in all geographic areas, with the largest gain in North America (25%). On a geographic basis, double-digit volume growth was reported in all geographic areas except Asia Pacific, which was up 9%. Growth in the emerging geographies continued to be robust, par- ticularly for the Performance segments, which re- ported a combined 13% increase in volume. Volume growth also continued to be notable in Latin America and Eastern Europe, both of which reported double- digit increases.

Fourth Quarter 2010 Highlights:

The Company reported earnings of $0.37 per share, or $0.47 per share excluding certain items.(2) This compares with earnings of $0.08 per share in the year-ago period, or $0.18 per share excluding certain items.

Sales of $13.8 billion rose 22 percent versus the same quarter last year. Sales increased double-digits in all geographic areas and in all operating segments except Coatings and Infrastructure, which rose 6 percent.

Health and Agricultural Sciences posted record fourth quarter sales of $1.3 billion. Volume grew 20 percent with gains in every geographic area, led by 35 percent growth in Latin America.

Sales from emerging regions were $4.5 billion, reaching a new quarterly record for the Company. This was driven by volume growth in Thailand (33%), India (31%), Russia (30%), and Brazil (14%).

Net debt to total capitalization declined to 42.6%, 240 basis points below the Company‘s year-end goal. This was primarily due to $1.8 billion of cash flow from operating activities.

Equity earnings reached an all-time quarterly record of $313 million.

EBITDA(4) was $1.9 billion, an increase of 30 per- cent versus the year-ago period.

At the Company level, EBITDA margin expanded more than 200 basis points, representing the seventh consecutive quarter of year-over-year margin ex- pansion. Margin expanded in Plastics by 520 basis points. And Performance Products and Performance Systems together expanded margin by more than 230 basis points. http://www.dow.com

E

.I. DuPont de Nemours and Company, Inc., and Evonik Degussa GmbH of Marl, Germany,

have signed a license agreement which solely grants DuPont worldwide access to the multi-shot or 2K molding technology patented by Evonik for nylon 6,6 and nylon 6. The licensed technology enables the eli- mination of process steps in the production of two-

11-02/03 :: February / March 2011